$299 Million is the total value of Endurant Capital Management LP's 88 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | Buy | ALLERGAN PLC | $16,893,000 | +129.2% | 73,100 | +165.8% | 5.65% | +136.5% |
| SHPG | Buy | SHIRE PLCsponsored adr | $14,431,000 | +111.2% | 78,396 | +97.2% | 4.82% | +117.9% |
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $14,267,000 | +0.7% | 234,729 | +1.5% | 4.77% | +3.9% |
| HLS | Buy | HEALTHSOUTH CORP | $14,228,000 | +3.4% | 366,513 | +0.2% | 4.76% | +6.7% |
| MCK | Buy | MCKESSON CORP | $13,185,000 | +93.4% | 70,638 | +63.0% | 4.41% | +99.6% |
| ABT | Buy | ABBOTT LABS | $12,088,000 | +1339.0% | 307,502 | +1431.1% | 4.04% | +1385.7% |
| WMGI | Buy | WRIGHT MED GROUP N V | $9,936,000 | +426.8% | 572,028 | +403.4% | 3.32% | +443.5% |
| CNC | Buy | CENTENE CORP DEL | $7,282,000 | +56.0% | 102,038 | +34.5% | 2.43% | +60.9% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $6,176,000 | +30.5% | 47,412 | +17.3% | 2.06% | +34.6% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $5,888,000 | +12.6% | 43,907 | +4.8% | 1.97% | +16.2% |
| HOLX | Buy | HOLOGIC INC | $5,820,000 | +173.4% | 168,208 | +172.6% | 1.94% | +181.9% |
| DVA | Buy | DAVITA HEALTHCARE PARTNERS I | $4,167,000 | +39.2% | 53,889 | +32.1% | 1.39% | +43.6% |
| AMGN | Buy | AMGEN INC | $4,002,000 | +376.4% | 26,300 | +369.6% | 1.34% | +391.9% |
| ABC | New | AMERISOURCEBERGEN CORP | $3,855,000 | – | 48,600 | +100.0% | 1.29% | – |
| CRL | Buy | CHARLES RIV LABS INTL INC | $3,305,000 | +299.6% | 40,088 | +268.2% | 1.10% | +312.3% |
| LHCG | New | LHC GROUP INC | $3,125,000 | – | 72,200 | +100.0% | 1.04% | – |
| JNJ | New | JOHNSON & JOHNSON | $2,972,000 | – | 24,500 | +100.0% | 0.99% | – |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $2,614,000 | +46.1% | 207,468 | +76.5% | 0.87% | +50.7% |
| STE | New | STERIS PLC | $2,317,000 | – | 33,700 | +100.0% | 0.77% | – |
| SRCL | New | STERICYCLE INC | $2,311,000 | – | 22,200 | +100.0% | 0.77% | – |
| CELG | Buy | CELGENE CORP | $2,257,000 | +57.9% | 22,880 | +60.2% | 0.75% | +62.9% |
| NTUS | New | NATUS MEDICAL INC DEL | $1,830,000 | – | 48,400 | +100.0% | 0.61% | – |
| TNDM | Buy | TANDEM DIABETES CARE INC | $1,739,000 | +7.6% | 230,671 | +24.3% | 0.58% | +10.9% |
| BBH | New | VANECK VECTORS ETF TRbiotech etf | $1,668,000 | – | 16,300 | +100.0% | 0.56% | – |
| MD | New | MEDNAX INC | $1,231,000 | – | 17,000 | +100.0% | 0.41% | – |
| CVS | Buy | CVS HEALTH CORP | $1,090,000 | +23.6% | 11,385 | +33.9% | 0.36% | +27.3% |
| CTLT | New | CATALENT INC | $929,000 | – | 40,400 | +100.0% | 0.31% | – |
| BAX | New | BAXTER INTL INC | $900,000 | – | 19,909 | +100.0% | 0.30% | – |
| WAT | New | WATERS CORP | $872,000 | – | 6,200 | +100.0% | 0.29% | – |
| GI | Buy | ENDOCHOICE HLDGS INC | $829,000 | +21.7% | 169,163 | +29.4% | 0.28% | +25.3% |
| SSRG | Buy | SYMMETRY SURGICAL INC | $812,000 | +73.9% | 61,819 | +30.6% | 0.27% | +79.5% |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $808,000 | +127.6% | 40,100 | +197.0% | 0.27% | +134.8% |
| DERM | Buy | DERMIRA INC | $766,000 | +180.6% | 26,188 | +98.6% | 0.26% | +190.9% |
| PARNF | Buy | PARNELL PHARMACEUT HLDGS LTD | $732,000 | -10.9% | 448,802 | +16.3% | 0.24% | -7.9% |
| NLNK | New | NEWLINK GENETICS CORP | $704,000 | – | 62,491 | +100.0% | 0.24% | – |
| HWAY | Buy | HEALTHWAYS INC | $693,000 | +34.0% | 60,016 | +17.2% | 0.23% | +38.9% |
| PRGO | Buy | PERRIGO CO PLC | $689,000 | +49.5% | 7,600 | +111.1% | 0.23% | +54.4% |
| INCY | Buy | INCYTE CORP | $664,000 | +17.5% | 8,300 | +6.4% | 0.22% | +21.3% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $641,000 | +23.7% | 14,100 | +7.6% | 0.21% | +27.4% |
| CI | Buy | CIGNA CORPORATION | $523,000 | +104.3% | 4,089 | +119.1% | 0.18% | +110.8% |
| MTD | New | METTLER TOLEDO INTERNATIONAL | $401,000 | – | 1,100 | +100.0% | 0.13% | – |
| PCRX | New | PACIRA PHARMACEUTICALS INC | $354,000 | – | 10,500 | +100.0% | 0.12% | – |
| NVLS | Buy | NIVALIS THERAPEUTICS INC | $303,000 | +134.9% | 65,783 | +112.3% | 0.10% | +140.5% |
| RDUS | New | RADIUS HEALTH INC | $301,000 | – | 8,200 | +100.0% | 0.10% | – |
| ARA | New | AMERICAN RENAL ASSOCIATES HO | $246,000 | – | 8,500 | +100.0% | 0.08% | – |
| Buy | TRILLIUM THERAPEUTICS INC | $245,000 | +111.2% | 27,300 | +118.4% | 0.08% | +115.8% | |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $245,000 | – | 9,800 | +100.0% | 0.08% | – |
| RXDX | New | IGNYTA INC | $109,000 | – | 20,200 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.